Vivek Mittal Professor of Cell and Developmental Biology in Cardiothoracic Surgery

Ford-Isom Research Professor of Cardiothoracic Surgery, Cardiothoracic Surgery , Weill Cornell Medical College 2020 -
Professor of Cell and Developmental Biology in Cardiothoracic Surgery, Cardiothoracic Surgery , Weill Cornell Medical College 2016 -

Research

Sort by

Co-investigator Network

Therapeutic targeting of the tumor microenvironment in triple negative breast cancer patients at high risk of relapse and preclinical models of lung metastases awarded by United States Department of Defense Principal Investigator 2025 - 2029
ER stress-driven IRE1a-XBP1 signaling in lung cancer awarded by National Cancer Institute Principal Investigator 2023 - 2028
Immunoregulatory role of lung-resident club cell factors in lung cancer awarded by National Cancer Institute Principal Investigator 2023 - 2028
Copper-Mediated Metabolic Reprogramming And ECM Alterations In TNBC Metastasis awarded by National Cancer Institute Principal Investigator 2021 - 2026
Targeting IL-1RAP to overcome EGFR-TKIs resistance in EGFR mutant NSCLC awarded by Cantargia AB Principal Investigator 2021 - 2025

Discovery of a stem cell driving breast cancer spine metastases awarded by National Cancer Institute Co-Investigator 2024 - 2029
PICI Grant and Main Collaboration Agreement with Multiple Subprojects awarded by Parker Institute for Cancer Immunotherapy Co-Investigator 2024 - 2028
Targeting cytidine deaminase-induced chromosomal instability as a driver of metastasis in bladder cancer awarded by Starr Cancer Consortium Co-Investigator 2023 - 2025

CAP-IT Center for LNP RNA Immunoprevention awarded by National Cancer Institute Co-Principal Investigator 2022 - 2027
Intercepting progression from pre-invasive to invasive lung adenocarcinoma awarded by National Cancer Institute Co-Principal Investigator 2019 - 2025

Evaluating Lymph Node T Cell "Clonal Replacement" in a Phase II Trial of Neoadjuvant SBRT plus Cemiplimab versus Chemotherapy plus Cemiplimab in Resectable NSCLC awarded by WCM Sandra and Edward Meyer Cancer Center Key Personnel 2025 - 2026
Elucidating the oncogenic role of EMSY in non-small cell lung cancer awarded by United States Department of Defense Key Personnel 2024 - 2026
Modulation of CD8+ T cell differentiation and anti-tumor immunity by metabolic manipulation awarded by National Center for Advancing Translational Sciences Key Personnel 2024 - 2026
Genetically engineered stem cell like T cells for the treatment of NSCLC awarded by American Association for Thoracic Surgery Key Personnel 2024 - 2026
To study the EMT contributions in tumor metastasis and chemoresistance by using lineage tracing models awarded by National Cancer Institute Key Personnel 2020 - 2026
missing activity Key Personnel 2024 - 2025
missing activity Key Personnel 2023 - 2025
Targeting APOBEC3A-induced chromosomal instability as a driver of metastasis in bladder cancer Key Personnel 2023 - 2025

Therapeutic targeting of the tumor microenvironment in triple negative breast cancer patients at high risk of relapse and preclinical models of lung metastases awarded by National Cancer Institute Principal Investigator Subaward 2025 - 2030